ARTICLE
15 February 2022

Views From The Market Podcast: Episode 26 - Healthcare M&A During And After The Pandemic

SE
Stikeman Elliott LLP

Contributor

Stikeman Elliott LLP logo
Stikeman Elliott is a global leader in Canadian business law and the first call for businesses working in and with Canada. We provide clients with the highest quality counsel, strategic advice, and creative solutions. Stikeman Elliott consistently ranks as a top law firm in our primary practice areas. www.stikeman.com
To help us understand the business impacts of COVID-19 on the healthcare industry, Mario Nigro spoke to Cathy Steiner, Principal at Origin Merchant Partners and leader of their healthcare practice.
Canada Food, Drugs, Healthcare, Life Sciences

To help us understand the business impacts of COVID-19 on the healthcare industry, Mario Nigro spoke to Cathy Steiner, Principal at Origin Merchant Partners and leader of their healthcare practice. Interest in healthcare businesses has soared during the pandemic as investors search out innovators in areas like virtual and telemedicine. As Cathy notes, the technological innovation that COVID-19 has necessitated is likely to change the sector for the long term.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More